Physiologic changes in pregnancy and their effect on drug disposition.
about
Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growthPerfluorinated chemicals and fetal growth: a study within the Danish National Birth CohortA revised probabilistic estimate of the maternal methyl mercury intake dose corresponding to a measured cord blood mercury concentration.Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentEpidemiology of medications use in pregnancyBupropion metabolism by human placenta.Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings.The association between nonylphenols and sexual hormones levels among pregnant women: a cohort study in Taiwan.Vascular Complications of Systemic Sclerosis during Pregnancy.Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC.Quantitative determination of metformin, glyburide and its metabolites in plasma and urine of pregnant patients by LC-MS/MS.Prenatal maternal blood triglyceride and fatty acid levels in relation to exposure to di(2-ethylhexyl)phthalate: a cross-sectional studyPharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant womenQuantitative determination of pravastatin and its metabolite 3α-hydroxy pravastatin in plasma and urine of pregnant patients by LC-MS/MSPharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006.Plasma levels of oral risperidone during enteral nutrition in a pregnant schizophrenic patient.Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study.Antibiotic therapy in pregnancy and lactation.Pharmacokinetics of monoclonal antibodies used for inflammatory bowel diseases in pregnant women.Pharmacologic evidence to support clinical decision making for peripartum methadone treatment.Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.The fate and effects of xenobiotics in human placenta.Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy.The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women.Pharmacokinetics in special populations.Renal and Hepatic Functions after A Week of Controlled Ovarian Hyperstimulation during In Vitro Fertilization Cycles.Physiologic and pharmacokinetic changes in pregnancy.Antipsychotic use in pregnancy.Use of medication for cardiovascular disease during pregnancy.A Review of Antibiotic Use in Pregnancy.Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment.Medication use and drug-related problems among women at maternity wards-a cross-sectional study from two Norwegian hospitals.Pharmacologic Considerations for Solid Organ Transplant Recipients Who Become Pregnant.Retrospective analysis of the associations and effectiveness of performing therapeutic drug monitoring in pregnant HIV-positive women in two large centres in Manchester.Investigating the Frequency and Nature of Medication-Related Problems in the Women's Health Unit of an Australian Tertiary Teaching Hospital.Transplacental exchange of moxidectin after maternal or fetal intravenous administration in sheep.Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia?Plasma disposition kinetics of moxidectin after subcutaneous administration to pregnant sheep.
P2860
Q24647791-B28E6429-666E-4B83-A591-C186C4F63C23Q24680484-483209BB-D342-4E6E-ABE4-FA43478E345AQ24814152-61B7D658-BECC-4597-8FFF-C01BC1F579A0Q26766128-B4AA2B39-DE6A-405A-B970-C444DAE0DA86Q28083692-914596A2-3EBA-41BD-A3C3-E06318D611C5Q33759322-6666CD1D-DEAA-4FD0-A4E0-23B1394B9DD1Q33968260-928982E3-DABF-4BBA-8065-988CE6A2EEDBQ34078556-E2FA6BB7-8752-4318-A331-0CEBBB328B58Q34097385-17C2AEF4-01A4-424A-ADC0-7EB724C6F118Q34669043-38195538-7095-4090-8E2A-165A838CAF88Q35130840-19303115-CE86-4E58-B703-AEDCC76DB7A7Q35614427-07F0DFC9-EAF4-4563-9AAE-FDF093997296Q35636071-166389A3-387F-415C-B446-B6D9D13DF6F2Q35770834-FDC3FDFD-BBC0-4C86-AD1C-8BE7CBE18AFDQ35827743-AFAE9DB3-D619-4C9F-B99D-62C728D6C5A9Q35891733-41C781D5-5C2D-4164-A649-9CF7CD177B76Q35906549-239B9A0C-6166-43EF-9CA9-6D46719E5D5AQ35941792-21F51CF9-120A-4760-A572-010B35AF254FQ36141845-B3AD532D-0B1B-4F19-AD60-2EA5F8D70A68Q36239177-704E7920-6BFB-4757-B844-F92E610A2585Q36511123-EEB9B07E-988A-4653-A2D5-CDDFAFF48B1AQ36635719-F999448D-7948-4BC5-AF65-118AD7C337FCQ36810933-22A9FE43-5D1C-4480-A949-C598AF84A399Q36835803-83ACCD76-CB94-49CE-A972-E9CFFB6CA71FQ36846075-534275FB-977F-42A8-A47A-A879E2B0E884Q37175822-5256AEBB-7996-4ECD-A6EC-14C5CD834F32Q37550561-63FFB502-E4BF-4A6E-A41D-330D42417860Q37561732-7C0FC381-CFCA-4B11-A510-01D76CE1CB3CQ37695386-A897D772-B28E-4540-B7A1-68D5920E70A1Q38498051-379B0D0D-A720-4882-9B0B-DE51B3F528EDQ38639052-D1861B9D-7961-42C6-A7D3-034349003AA5Q38644820-C0E14334-709C-45AF-B779-57E048328019Q38681424-6AE309CD-4BB9-48EA-AA38-6AAF36ECA9DCQ38792368-5D147A56-24A0-40E2-A840-8AD6A2DDCC8FQ38893967-F475C26F-675B-4707-A671-BDAA5844F426Q40686492-7A5F0477-6142-4F3E-8382-211441C6E091Q41021126-1EB7B6AA-8A4A-4C72-A94C-9B36568FD1BEQ43073550-D314CFD6-05CF-4689-B16A-418AFB2C6B2EQ44449808-442AF8A0-3621-4146-82C9-8D2C7E26358BQ46260737-552B893D-B00E-4567-A950-AFF70A094DD0
P2860
Physiologic changes in pregnancy and their effect on drug disposition.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Physiologic changes in pregnancy and their effect on drug disposition.
@ast
Physiologic changes in pregnancy and their effect on drug disposition.
@en
Physiologic changes in pregnancy and their effect on drug disposition.
@nl
type
label
Physiologic changes in pregnancy and their effect on drug disposition.
@ast
Physiologic changes in pregnancy and their effect on drug disposition.
@en
Physiologic changes in pregnancy and their effect on drug disposition.
@nl
prefLabel
Physiologic changes in pregnancy and their effect on drug disposition.
@ast
Physiologic changes in pregnancy and their effect on drug disposition.
@en
Physiologic changes in pregnancy and their effect on drug disposition.
@nl
P356
P1476
Physiologic changes in pregnancy and their effect on drug disposition.
@en
P2093
Frederiksen MC
P304
P356
10.1053/SPER.2001.24565
P577
2001-06-01T00:00:00Z